about
Natural Products for AntithrombosisReview of continuing education course on hemostasis.Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases.Ruthenium-conjugated chrysin analogues modulate platelet activity, thrombus formation and haemostasis with enhanced efficacyModulation of platelet activation and thrombus formation using a pan-PI3K inhibitor S14161.Inhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modelingSimulation of the microscopic process during initiation of stent thrombosis.Chlorogenic acid inhibits human platelet activation and thrombus formation.Inhibitory effects of yuzu and its components on human platelet aggregationA Potential Mechanism of High-Dose Ticagrelor in Modulating Platelet Activity and Atherosclerosis Mediated by Thymic Stromal Lymphopoietin Receptor.Regulation of Early Steps of GPVI Signal Transduction by Phosphatases: A Systems Biology Approach.Pharmacological actions of nobiletin in the modulation of platelet function.Ginsenoside-Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activation.Insights into dietary flavonoids as molecular templates for the design of anti-platelet drugsDual Roles of Quercetin in Platelets: Phosphoinositide-3-Kinase and MAP Kinases Inhibition, and cAMP-Dependent Vasodilator-Stimulated Phosphoprotein StimulationLysyl oxidase is associated with increased thrombosis and platelet reactivity.Thrombosis recanalization by paeoniflorin through the upregulation of urokinase‑type plasminogen activator via the MAPK signaling pathway.Antithrombotic effect of Z4A5 on coronary thrombosis in a canine model of acute unstable angina.Scorpion peptides: potential use for new drug developmentPlatelet receptors and signaling in the dynamics of thrombus formation.Protective Mechanisms of S. lycopersicum Aqueous Fraction (Nucleosides and Flavonoids) on Platelet Activation and Thrombus Formation: In Vitro, Ex Vivo and In Vivo StudiesComputational simulation of platelet interactions in the initiation of stent thrombosis due to stent malappositionAnticoagulant and Antiplatelet Activities of Artemisia princeps Pampanini and Its Bioactive Components.Targeting von Willebrand factor as a novel anti-platelet therapy; application of ARC1779, an Anti-vWF aptamer, against thrombotic risk.Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease.Mechanism of the anti-platelet effect of natural bioactive compounds: role of peroxisome proliferator-activated receptors activation.Relationship between Platelet PPARs, cAMP Levels, and P-Selectin Expression: Antiplatelet Activity of Natural Products.Gap junctions and connexin hemichannels in the regulation of haemostasis and thrombosis.Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database.Medicinal Plants with Antiplatelet Activity.Beneficial effect of anti-platelet therapies on atherosclerotic lesion formation assessed by phase-contrast X-ray CT imaging.Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation.Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.Mechanisms underlying the inhibitory effects of lipopolysaccharide on human platelet adhesion.Inhibitory Effect of Propolis on Platelet Aggregation In Vitro.Identification of the active region responsible for the anti-thrombotic activity of anopheline anti-platelet protein from a malaria vector mosquito.Anti-platelet activity of erythro-(7S,8R)-7-acetoxy-3,4,3',5'-tetramethoxy-8-O-4'-neolignan from Myristica fragrans.Protective mechanisms of guanosine from Solanum lycopersicum on agonist-induced platelet activation: role of sCD40L.Curcumin, hemostasis, thrombosis, and coagulation.Sulfasalazine and its metabolites inhibit platelet function in patients with inflammatory arthritis.
P2860
Q28084934-EAAE7259-3F82-43D7-BEA4-9F09D37E1B23Q33393140-8C0CC009-150D-4E3C-A6EE-5BE997E21971Q33685876-2E7247E2-251E-4AE9-ABF1-4DDC00E77D63Q33915894-B00EA108-B587-4DC9-832F-B60AE393D891Q34034814-383FACAF-EEA1-4CD9-BFC6-A6106837D230Q34506411-AB0EF026-4C62-41CA-B69B-8C81D2796092Q34758865-1C434985-440F-4EB0-BF70-114B5461E1B4Q35112024-68685CEB-2B9C-4AE9-B031-17D1F9C3D741Q35161282-E7306610-F239-4316-A393-DEC9F8483FD9Q35827283-BA0A0BE7-BB82-4C4F-AEF3-F06577B3135FQ35846181-45FA3DCC-513B-4BF0-966A-6F9A248C08B3Q35978127-109B14A7-F645-4935-AF93-329F74263FE1Q36252847-8E42E497-D068-46D8-A9CB-43BC67A34C03Q36481344-F73F0F6C-9638-4547-B5F3-CE0BB837A78AQ36497829-C1EC8DC2-BABB-4121-9F41-0BAAA24F15FCQ36700494-A104696E-63DB-41AC-992B-3A15992F8F04Q36931196-C234311E-6A78-4B1C-A708-89816B65676EQ36943257-545EFEE4-EDF9-4994-8141-A526A5298EE0Q36971525-AB85A6AD-E634-4A7F-9479-76A7607FC0C1Q37175605-3850DD3E-AC13-4485-B487-241968AE5B17Q37212771-6A9741A3-50D1-4D7C-A8A2-F5E776C04141Q37289877-04007DA0-612C-4042-9695-6D6FC00AA097Q37481470-25F443DE-A5E9-45E0-B0F1-B70A18625F68Q38058760-10E8EB7E-264C-4CFF-8053-9C8E94A7C64BQ38132823-E6EA2270-3403-4D41-9C13-0F29421F48B6Q38163612-2BEE8CA1-FA01-4311-BC89-5FF76E01B71DQ38170115-BEA8330A-1106-47E5-AC07-B4E1C7F360D4Q38502107-30CB2D28-05CA-47AA-85E8-3D4D158B79A7Q38653041-4B09D2E3-6377-45AE-9EEF-B99018365F18Q38803630-4BAF9C1E-B75D-41C7-8EAD-46D75878A356Q39737585-6223310B-F0F1-4196-B7AA-B65D717043C7Q42279248-A2030A45-D997-46EE-8964-792F02191253Q42485137-EE0FD6BA-8B68-45C4-9D3B-FD8F11434FC0Q43135345-72BCF380-E50E-4A38-91BD-9B04D13F5515Q43453844-5AFB6A1F-0667-4A50-B611-DAB00B8A354FQ44164674-01EF925B-B4F3-4BCD-98F8-0BFDA8396980Q44528734-DEAC3AE8-B42C-4BEF-B82E-8968389E885CQ45326449-9983AF7D-B29F-488C-BA8C-97771C5A7CABQ48156313-0B31C712-B2BD-4E9B-9C21-E5D95D72AF16Q50449062-03E28A14-C622-4E52-A768-DFE36D7F3EAF
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Future innovations in anti-platelet therapies.
@en
type
label
Future innovations in anti-platelet therapies.
@en
prefLabel
Future innovations in anti-platelet therapies.
@en
P2093
P2860
P356
P1476
Future innovations in anti-platelet therapies
@en
P2093
J M Gibbins
K L Tucker
L A Moraes
R G Stanley
W J Kaiser
P2860
P304
P356
10.1038/BJP.2008.151
P407
P577
2008-04-21T00:00:00Z